Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Bioniche Pharma was a leading developer and manufacturer of branded and generic injectable pharmaceuticals for hospital and primary care markets. As of its acquisition by Mylan in 2010, it had over 30 marketed products across several therapeutic areas with significant investments in its pipeline including at least 15 ANDAs pending FDA approval and more than 25 additional products in development. Most sales were derived from the U.S. market.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Bioniche Pharma.